The University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) and the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) have signed an MOU focused on global animal health. The collaboration will include process development and vaccine manufacturing that will focus on emerging infectious livestock diseases affecting primarily low-and-middle-income countries. “Collaborating with the CVIM is a vital step towards establishing a global network of key groups with the capacity to drive discovery innovations to commercial readiness,” said VIDO Director Dr Volker Gerdts. “This MOU reinforces VIDO’s commitment to addressing infectious diseases of global importance and foster vaccine commercialization as Canada’s Centre for Pandemic Research.”
Top Ten News
USask VIDO, CVIM sign MOU focused on global animal health
News